Statistical frameworks for setting cutoff points of metabolic syndrome criteria

References

• Alberti, K. G., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J. C., James, W. P., Loria, C. M., Smith, S. C. Jr. (2009). International fiabetes federation task force on epidemiology and Prevention, National Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity: Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645.
   Google Scholar
• Alberti, K. G., Zimmet, P. Z. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine 15:539–553.
   Google Scholar
• Alberti, K. G., Zimmet, P., Shaw. (2005). IDF epidemiology task force consensus group. The metabolic syndrome: A new worldwide definition. Lancet 366:1059–1062.
   Google Scholar
• Balkau, B., Charles, M. A. (1999). Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabetic Medicine 16:442–443.
   Google Scholar
• Einhorn, D., Reaven, G. M., Cobin, R. H, Ford, E., Ganda, O. P., Handelsman, Y., Hellman, R., Jellinger, P. S., Kendall, D., Krauss, R. M., Neufeld, N. D., Petak, S. M., Rodbard, H. W., Seibel, J. A., Smith, D. A., Wilson, P. W. (2003). American College of Endocrinology position statement on the insulin resistance syndrome. Endocrine Practice 9:237–252.
   Google Scholar
• Expert Panel on Detection and Evaluation of Treatment of High Blood Cholesterol in Adults. (2001). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486–2497.
   Google Scholar
• Ford, E. S., Giles, W. H., Dietz, W. H. (2002). Prevalence of metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 287(3):356–359.
   Google Scholar
• Grundy, S. M., Brewer, H. B., Jr., Cleeman, J. I., Smith, S. C. Jr., Lenfant, C. (2004). Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arteriosclerosis, Thrombosis, and Vascular Biology 24:e13–e18.
   Google Scholar
• Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., Jr., Spertus, J. A., Costa, F. (2005). American Heart Association; National Heart, Lung, and Blood Institute: Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiology in Review 13:322–327.
   Google Scholar
• Johnson, R. J., Stenvinkel, P., Martin, S. L., Jani, A., Sanchez-Lozada, L. G., Hill, J. O., Lanaspa, M. A. (2013). Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology. Obesity (Silver Spring) 21(4):659–664.
   Google Scholar
• Kassi, E., Pervanidou, P., Kaltsas, G., Chrousos, G. (2011). Metabolic syndrome: Definitions and controversies. BMC Medicine 9:48–60.
   Google Scholar
• Kylin, E. (1923). Studien ueber das Hypertonie-Hyperglykamie Hyperurikamiesyndrom. Zentralbl Innere Medizin 44:105–127.
   Google Scholar
• Moebus, S., Hanisch, J. U., Neuhäuser, M., Aidelsburger, P., Wasem, J., Jöckel, K. H. (2006). Assessing the prevalence of the Metabolic Syndrome according to NCEP ATP III in Germany: Feasibility and quality aspects of a two-step approach in 1550 randomly selected primary health care practices. German Medical Science 4:Doc07.
   Google Scholar
• Morris, J. A., Gardner, M. J. (1988). Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. Statistics in Medicine 296:1313–1316.
   Google Scholar
• Mottillo, S., Filion, K. B., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Schiffrin, E. L., Eisenberg, M. J. (2010). The metabolic syndrome and cardiovascular risk: A systematic review and meta-analysis. Journal of the American College of Cardiology 56(14):1113–1132.
   Google Scholar
• Parikh, R. M., Joshi, S. R., Menon, P. S., Shah, N. S. (2007). Index of central obesity—A novel parameter. Medical Hypotheses 68:1272–1275.
   Google Scholar
• Parikh, R. M., Mohan, V. (2012). Changing definitions of metabolic syndrome. Indian Journal of Endocrinology and Metabolism 16(1):7–12.
   Google Scholar
• Prabhakaran, D., Reddy, K. S. (2011). The metabolic syndrome: Looking beyond the debates. Clinical Pharmacology and Therapeutics 90:19–21.
   Google Scholar
• Reaven, G. M. (1988). Role of insulin resistance in human disease. Diabetes 37:1595–1607.
   Google Scholar
• Reaven, G. M. (2005). The metabolic syndrome: Requiescat in pace. Clinical Chemistry 51(6):931–938.
   Google Scholar
• Reaven, G. M. (2006). The metabolic syndrome: Is this diagnosis necessary? American Journal of Clinical Nutrition 83:1237–1247.
   Google Scholar
• Reaven, G. M. (2011). The metabolic syndrome: Time to get off the merry-go-round? Journal of Internal Medicine 269:127–136.
   Google Scholar
• Sen, P. K., Singer, J. M. (1993). Large Sample Methods in Statistics: An Introduction with Applications. New York: Chapman & Hall.
   Google Scholar
• Simmons, R. K., Alberti, K. G. M. M., Gale, E. A. M., Colagiuri, S., Tuomilehto, J., Qiao, Q., Ramachandran, A., Tajima, N., Brajkovich Mirchov, I., Ben-Nakhi, A., Reaven, G., Hama Sambo, B., Mendis, S., Roglic, G. (2010). The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia 53:600–605.
   Google Scholar
• Thaman, R. G., Arora, G. P. (2013). Metabolic syndrome: Definition and pathophysiology—The discussion goes on! Journal of Physiology and Pharmacology Advances 3(3):48–56.
   Google Scholar
• Vague, J. (1956). The degree of masculine differentiation of obesities: A factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. American Journal of Clinical Nutrition 4:20–34.
   Google Scholar